ACADIA Pharmaceuticals Inc —— 季度现金流量表 (NASDAQ:ACAD) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 1.19 B1.13 B1.23 B1.33 B1.56 B 负债总额 454.96 M367.13 M403.17 M413.5 M336.81 M 权益总额 732.79 M765.24 M822.38 M917.27 M1.23 B 负债及股东权益总额 1.19 B1.13 B1.23 B1.33 B1.56 B 总债务 ————— 净债务 —————

ACADIA Pharmaceuticals Inc

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

新闻

CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?

Will Acadia (ACAD) Beat Estimates Again in Its Next Earnings Report?

Biotech Is Holding Steady In 2026 (NASDAQ:IBB)

Why Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

AXSM's 2025 Revenue Surge Largely Driven by Auvelity: What's Ahead?

JAZZ or ACAD: Which Is the Better Value Stock Right Now?

Acadia Pharmaceuticals任命Jonathan M. Poole为董事会成员

Acadia Pharmaceuticals appoints Jonathan M. Poole to board of directors

ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU (Revised)

ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU

美国银行因欧盟挫折下调Acadia Pharmaceuticals目标价